Literature DB >> 21391610

Discovery and structure-activity relationship of 3-aminopyrid-2-ones as potent and selective interleukin-2 inducible T-cell kinase (Itk) inhibitors.

Jean-Damien Charrier1, Andrew Miller, David P Kay, Guy Brenchley, Heather C Twin, Philip N Collier, Sharn Ramaya, Shazia B Keily, Steven J Durrant, Ronald M A Knegtel, Adam J Tanner, Kieron Brown, Adam P Curnock, Juan-Miguel Jimenez.   

Abstract

Interleukin-2 inducible T-cell kinase (Itk) plays a role in T-cell functions, and its inhibition potentially represents an attractive intervention point to treat autoimmune and allergic diseases. Herein we describe the discovery of a series of potent and selective novel inhibitors of Itk. These inhibitors were identified by structure-based design, starting from a fragment generated de novo, the 3-aminopyrid-2-one motif. Functionalization of the 3-amino group enabled rapid enhancement of the inhibitory activity against Itk, while introduction of a substituted heteroaromatic ring in position 5 of the pyridone fragment was key to achieving optimal selectivity over related kinases. A careful analysis of the hydration patterns in the kinase active site was necessary to fully explain the observed selectivity profile. The best molecule prepared in this optimization campaign, 7v, inhibits Itk with a K(i) of 7 nM and has a good selectivity profile across kinases.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21391610     DOI: 10.1021/jm101499u

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  11 in total

1.  Identification of a Novel and Selective Series of Itk Inhibitors via a Template-Hopping Strategy.

Authors:  Catherine M Alder; Martin Ambler; Amanda J Campbell; Aurelie C Champigny; Angela M Deakin; John D Harling; Carol A Harris; Tim Longstaff; Sean Lynn; Aoife C Maxwell; Chris J Mooney; Callum Scullion; Onkar M P Singh; Ian E D Smith; Donald O Somers; Christopher J Tame; Gareth Wayne; Caroline Wilson; James M Woolven
Journal:  ACS Med Chem Lett       Date:  2013-08-12       Impact factor: 4.345

2.  Targeting interleukin-2-inducible T-cell kinase (ITK) and resting lymphocyte kinase (RLK) using a novel covalent inhibitor PRN694.

Authors:  Yiming Zhong; Shuai Dong; Ethan Strattan; Li Ren; Jonathan P Butchar; Kelsey Thornton; Anjali Mishra; Pierluigi Porcu; J Michael Bradshaw; Angelina Bisconte; Timothy D Owens; Erik Verner; Ken A Brameld; Jens Oliver Funk; Ronald J Hill; Amy J Johnson; Jason A Dubovsky
Journal:  J Biol Chem       Date:  2015-01-15       Impact factor: 5.157

3.  Targeting Interleukin-2-Inducible T-cell Kinase (ITK) in T-Cell Related Diseases.

Authors:  Yiming Zhong; Amy J Johnson; John C Byrd; Jason A Dubovsky
Journal:  Postdoc J       Date:  2014-06

4.  Substrate recognition of PLCγ1 via a specific docking surface on Itk.

Authors:  Qian Xie; Raji E Joseph; D Bruce Fulton; Amy H Andreotti
Journal:  J Mol Biol       Date:  2012-12-03       Impact factor: 5.469

5.  Discovery of novel irreversible inhibitors of interleukin (IL)-2-inducible tyrosine kinase (Itk) by targeting cysteine 442 in the ATP pocket.

Authors:  John D Harling; Angela M Deakin; Sébastien Campos; Rachel Grimley; Laiq Chaudry; Catherine Nye; Oxana Polyakova; Christina M Bessant; Nick Barton; Don Somers; John Barrett; Rebecca H Graves; Laura Hanns; William J Kerr; Roberto Solari
Journal:  J Biol Chem       Date:  2013-08-09       Impact factor: 5.157

6.  Oxyfunctionalization of pyridine derivatives using whole cells of Burkholderia sp. MAK1.

Authors:  Jonita Stankevičiūtė; Justas Vaitekūnas; Vytautas Petkevičius; Renata Gasparavičiūtė; Daiva Tauraitė; Rolandas Meškys
Journal:  Sci Rep       Date:  2016-12-16       Impact factor: 4.379

7.  Auto In Silico Ligand Directing Evolution to Facilitate the Rapid and Efficient Discovery of Drug Lead.

Authors:  Fengxu Wu; Linsheng Zhuo; Fan Wang; Wei Huang; Gefei Hao; Guangfu Yang
Journal:  iScience       Date:  2020-05-18

8.  Structure-functional prediction and analysis of cancer mutation effects in protein kinases.

Authors:  Anshuman Dixit; Gennady M Verkhivker
Journal:  Comput Math Methods Med       Date:  2014-04-08       Impact factor: 2.238

9.  Synthesis and profiling of a 3-aminopyridin-2-one-based kinase targeted fragment library: Identification of 3-amino-5-(pyridin-4-yl)pyridin-2(1H)-one scaffold for monopolar spindle 1 (MPS1) and Aurora kinases inhibition.

Authors:  Daren Fearon; Isaac M Westwood; Rob L M van Montfort; Richard Bayliss; Keith Jones; Vassilios Bavetsias
Journal:  Bioorg Med Chem       Date:  2018-04-17       Impact factor: 3.641

10.  Structure of LRRK2 in Parkinson's disease and model for microtubule interaction.

Authors:  C K Deniston; J Salogiannis; S Mathea; D M Snead; I Lahiri; M Matyszewski; O Donosa; R Watanabe; J Böhning; A K Shiau; S Knapp; E Villa; S L Reck-Peterson; A E Leschziner
Journal:  Nature       Date:  2020-08-19       Impact factor: 49.962

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.